Search Results - "First Line"

Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. by Kajiura, Shinya, Satake, Hironaga, Hayashi, Ryuji, Yoshino, Takayuki

View this record in EBSCOhost

Facility-Level Availability of Japanese Society of Medical Oncology Specialists and Recorded First-Line Treatment-Process Duration in Pancreatic Cancer: A Nationwide Center for Can... by Kajiura, Shinya, Satake, Hironaga, Nakamura, Naohiko, Hayashi, Ryuji

View this record in EBSCOhost

Cost-Effectiveness of First-Line Immunochemotherapy Versus BRAF Plus MEK Inhibitors in BRAF V600E -Mutated Metastatic Lung Cancer. by Chen, Chian-Wei, Tsai, Jui-Hung, Tsai, Sheng-Han, Chen, Li-Jun, Yang, Szu-Chun

View this record in EBSCOhost

Evolving First-Line Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: CDK4/6 Inhibition, Biomarker-Guided Strategies and Emerging Therapeutic Paradigms. by Abdel-Razeq, Hikmat, Sharaf, Baha

View this record in EBSCOhost

Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study. by Bao, Run, Qin, Jing, Zhang, Rong, Xu, Zhuo, Liu, Jiahao, Shen, Jiaofeng, Zhang, Shunji, Zhang, Yusong, Zhu, Hong, Huang, Chunyan, Lu, Yan, Liu, Tianhua, Pu, Wangyang

View this record in EBSCOhost

The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC. by Phillips, William J., Leong, Russell, Yeung, Benjamin, Al Lawati, Ahmed, Camidge, D. Ross, Lo, Bryan, Wheatley-Price, Paul

View this record in EBSCOhost

First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma. by Puckrin, Robert, Villa, Diego, Fleury, Isabelle, Larouche, Jean-François, Kuruvilla, John

View this record in EBSCOhost

Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study... by Rakušić, Zoran, Bišof, Vesna, Vušković, Sanja, Kotromanović, Zdenka, Erić, Suzana, Viculin, Jelena, Vazdar, Ljubica, Prpić, Marin, Kust, Davor, Vučinić, Damir

View this record in EBSCOhost

"Trust, Responsibility, and Making a Difference": Qualitative Insights into Why First-Line Managers in Healthcare Remain in Their Role. by Svanström, Jonas, Lindberg, Magnus, Skytt, Bernice, Lindberg, Maria

View this record in EBSCOhost

Overcoming Acquired MET-Driven Resistance to First-Line Lorlatinib: Successful Combination of Lorlatinib and Envafolimab in an ALK-Positive NSCLC Patient with Ultra-High PD-L1 Expr... by Ding, Lu, Nuersulitan, Reyizha, Wang, Jingjing, Chen, Hanxiao, Zhuo, Minglei

View this record in EBSCOhost

First-Line Pembrolizumab Monotherapy for Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Study from Vietnam. by Pham, Thi Huong, Pham, Cam Phuong, Nguyen, Thi Thu Huong, Nguyen, Khanh Toan

View this record in EBSCOhost

Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer. by Liu, Ke-Jun, Huang, Lin-Xuan, Jiang, Guan-Ming, Guo, Ning-Ning, Tan, Qing-Lin, Cai, Yan-Min, Chen, Shi-Yuan, Du, Wei, Fang, Nian-Xin, Jia, Jun

View this record in EBSCOhost

Clinical Outcomes and Immune-Related Adverse Events in Metastatic Non-Squamous NSCLC Treated with First-Line Pembrolizumab–Chemotherapy: A Real-World Study from Serbia. by Bojić, Zlatan, Marković, Filip, Kontić, Milica

View this record in EBSCOhost

Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study. by Rayson, Daniel, Bertin, Jonathan, Lemelin, Maxim, Tong, Madeline, Ng, Ryan, Ding, Philip, Cheung, Winson Y., Sharma, Arushi, On, Phu Vinh, Feugère, Guillaume, Lupichuk, Sasha

View this record in EBSCOhost

Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Pall... by Bartoszko, Jessica, Schroer, Julia, Cappello, Bernadette, Iyengar, Swathi, Goldkuhle, Marius, Skoetz, Nicole, Csenar, Mario, Moja, Lorenzo

View this record in EBSCOhost

Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. by Chen, Ping, Wang, Mengchi, Peng, Siyan, Zhu, Honglin, Wang, Yanming, Wan, Zixuan, Yang, Xuan, Yu, Zhixin, Zhou, Yixin

View this record in EBSCOhost

First-Line Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Real-World Outcomes and Prognostic Factors From a Vietnamese Cohort. by Nguyen, Huy Van, Dinh, Phuong Thi, Tran, Thang, Hoang, Cuc Thi

View this record in EBSCOhost

Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine–Cisplatin Plus PD-L1 Inhibitor: A Si... by Wu, Shuan, Xu, Jiawei, Li, Yan, Yu, Decai

View this record in EBSCOhost

A Podcast on Real-World Evidence with Avelumab First-Line Maintenance and Treatment Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma. by Grivas, Petros, Moon, Helen H.

View this record in EBSCOhost

Expanded span of control, leadership and management performance, work-related stress, and job satisfaction among first-line managers: A repeated cross-sectional study. by Svanström, Jonas, Skytt, Bernice, Lindberg, Maria, Lindberg, Magnus

View this record in EBSCOhost